Skip to main content
. 2015 Jun 8;17(9):763–769. doi: 10.1111/hpb.12426

Table 1.

Clinical characteristics

<Hemi-hepatectomy + Distal (n = 224) ≥Hemi-hepatectomy + Distal (n = 49) <Hemi-hepatectomy + PD (n = 183) ≥Hemi-hepatectomy + PD (n = 24) P-value
Age 58 (21–84) 58 (20–86) 64 (25–88) 53 (26–78) 0.001

Race

 White 170 (75.9) 35 (71.4) 144 (78.7) 17 (70.8) 0.460

 Black 26 (11.6) 5 (10.2) 12 (6.6) 2 (8.3)

 Asian 9 (4.0) 3 (6.1) 14 (7.7) 2 (8.3)

 Other 19 (8.5) 6 (12.2) 13 (7.1) 3 (12.5)

Female 129 (57.6) 24 (49) 191 (55.2) 9 (37.5) 0.232

BMI 28 (16–68) 26 (17–40) 27 (17–50) 26 (17–40) 0.071

Any Comorbidity (n = 380) 45 (26.5) 6 (16.2) 37 (24.5) 3 (15.8) 0.528

Smoker 27 (12.1) 7 (14.3) 32 (17.5) 1 (4.2) 0.213

Diabetes 43 (19.2) 3 (6.1) 35 (19) 3 (12.5) 0.114

COPD 5 (2.2) 2 (4.1) 7 (3.8) 0 (0) 0.652

HTN on medication 104 (46.4) 14 (28.6) 91 (49.7) 6 (25) 0.011

TIA (n = 273) 2 (1.6) 0 (0) 0 (0) 0 (0) 0.656

CVA (n-273) 1 (0.8) 0 (00 2 (1.9) 0 (0) 0.766

Sepsis 4 (1.8) 3 (6.1) 6 (3.3) 0 (0) 0.303

Pre-operative chemotherapy (n = 272) 5 (4.0) 3 (10) 8 (7.8) 1 (6.3) 0.423

Pre-operative Radiotherapy (n = 272) 4 (3.2) 0 (0) 3 (1.9) 0 (0) 0.695

Creatinine 0.8 (0.3–2.4) 0.9 (0.4–1.6) 0.8 (0.3–2.43) 0.84 (0.6–1.3) 0.472

Albumin 3.9 (1–5.1) 3.9 (2–4.8) 3.8 (1.6–5) 3.8 (2.1–5.1) 0.109

Bilirubin 0.6 (0.1–2.2) 0.6 (0.1–8.9) 0.6 (0.6–11.5) 0.7 (0.1–8.9) <0.001

Platelet 228 (40–588) 225 (106–428) 250 (23–620) 278 (166–590) 0.011

INR 1 (0.8–1.9) 1 (0.8–1.7) 1 (0.74–9.1) 1 (0.91–1.2) 0.878

ASA Class > 3 158 (70.5) 37 (75.5) 126 (68.9) 20 (83.3) 0.442

ASA, American Society of Anesthesiologist; TIA, transient ischaemic attack; HTN, hypertension; COPD, chronic obstructive pulmonary disease; BMI, body mass index; CVA, cerebral vascular attack; INR, International normalized ratio.